Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708434 · ClinicalTrials.gov registry record · NA
Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01708434: Completed NA study, sponsored by Ulthera.
NCT01708434 is a NA study that has completed, run by Ulthera. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01708434, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Enrolled subjects will receive one bilateral Ulthera® treatment on the knees. Up to 30 subjects will be enrolled. Study photos will be obtained prior to study treatment, immediately following study treatment, and at each post-treatment follow-up visit. Follow-up visits will occur at 90 and 180 days post-treatment.
Primary Outcome
Assessed based on Principal Investigator assessment using the Global Aesthetic Improvement Scale.
Interventions
- DEVICE Ulthera® System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-08 |
| Phase | NA |
What the finished NCT01708434 record still lists
NCT01708434 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Ulthera® System is the first listed.
NCT01708434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01708434 about?
NCT01708434 is a clinical study titled "Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees". Enrolled subjects will receive one bilateral Ulthera® treatment on the knees. Up to 30 subjects will be enrolled. Study photos will be obtained prior to study treatment, immediately following study treatment, and at each post-treatment follow-up visit. Follow-up visits will occur at 90 and 180 days ...
What is the current status of trial NCT01708434?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2011-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01708434?
The interventions under investigation include: Ulthera® System (DEVICE).
Who is sponsoring clinical trial NCT01708434?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01708434's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia